PH

Phillip Hains

Chimeric Therapeutics Limited | Non-Executive Director
Mr Hains is a operates a specialist CFO Services division at Acclime Australia. He has over 30 years' experience providing accounting, administration, compliance, and management services to businesses. He is a non-executive director of Chimeric Therapeutics Limited and Radiopharm Theranostics Limited.

Companies and Roles

Company
Title
Tenure
Since
CHM
CHM
Chimeric Therapeutics Limited
  • Non-Executive Director
5mthFeb 2026
FDV
FDV
Frontier Digital Ventures Limited
  • Interim Non-Executive Director,
8mthOct 2025
HXL
HXL
Hexima Limited
  • Non-Executive Director
2yrs, 9mthSep 2023

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
FDV
FDV
Frontier Digital Ventures Limited
31/10/250N/AN/AN/A
RAD
RAD
30/06/25N/A15,956,63216,833,562N/A
CHM
CHM
Chimeric Therapeutics Limited
30/06/25N/A12,934,7242,608,696N/A
HXL
HXL
Hexima Limited
18/09/230N/AN/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
CHM
CHM
Chimeric Therapeutics Limited
30/04/25
Issued
2,608,696$0.005$13,043Rights issue
CHM
CHM
Chimeric Therapeutics Limited
30/04/25
Issued
2,608,696$0.005$13,043Rights issue
RAD
RAD
16/12/24
Issued
8,000,000$0.027$216,000Issue of options
RAD
RAD
13/09/24
Issued
4,850,000$0.030$145,500Placement
RAD
RAD
13/09/24
Issued
9,700,000$0.040$388,000Placement